A carregar...
FDA-Approved Oligonucleotide Therapies in 2017
Oligonucleotides (oligos) have been under clinical development for approximately the past 30 years, beginning with antisense oligonucleotides (ASOs) and apatmers and followed about 15 years ago by siRNAs. During that lengthy period of time, numerous clinical trials have been performed and thousands...
Na minha lista:
| Publicado no: | Mol Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Gene & Cell Therapy
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5417833/ https://ncbi.nlm.nih.gov/pubmed/28366767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2017.03.023 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|